Phase 3, Randomized, Double-Blind Study to Evaluate the Safety and Efficacy of Stribild Versus Atripla in Human Immunodeficiency Virus, Type 1 (HIV-1) Infected, Antiretroviral Treatment-Naive Adults
This study is ongoing, but not recruiting participants.
Study NCT01095796
Information provided by Gilead Sciences
First Received on March 17, 2010.
Last Updated on December 10, 2012
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
